Patents by Inventor Eric Sartori

Eric Sartori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide thiadiazole inhibitors of plasminogen activator inhibitor-1
    Publication number: 20050143384
    Abstract: Methods of treating disorders associated with elevated levels of PAI-1 are disclosed comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of formula at least one compound of formula (I), or a pharmaceutically-acceptable salt, prodrug, stereoisomer or solvate thereof, wherein: A is aryl or heteroaryl and R1—R11, are defined herein. The invention also pertains to pharmaceutical compositions and compounds within the scope of formula (I) as well as medicaments and articles of manufacture comprising compounds of formula (I).
    Type: Application
    Filed: October 20, 2004
    Publication date: June 30, 2005
    Inventors: Eric Sartori, Magali Maillet, Marie Paugam, Eric Nicolai, Michael Lawrence
  • Urea thiadiazole inhibitors of plasminogen activator inhibior-1
    Publication number: 20050124664
    Abstract: Methods of treating disorders associated with elevated levels of PAI-1 are disclosed comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of formula (I), or a pharmaceutically-acceptable salt, prodrug, stereoisomer or solvate thereof, wherein: A is aryl o heteroaryl, and R1-R12, are defined herein. The invention also pertains to pharmaceutical compositions and compounds within the scope of formula (I) as well as medicaments and articles of manufacture comprising compounds of formula (I).
    Type: Application
    Filed: October 20, 2004
    Publication date: June 9, 2005
    Inventors: Eric Sartori, Magali Maillet, Marie Paugam, Eric Nicolai, Michael Lawrence
  • Oxamide inhibitors of plasminogen activator inhibitor-1
    Publication number: 20050124667
    Abstract: Methods of treating disorders associated with elevated levels of PAI-1 are disclosed comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of formula at least one compound of formula (I), or a pharmaceutically-acceptable salt, prodrug, stereoismer or solvate thereof, wherein: A is aryl or heteroaryl, X is O or S, and R1-R9 and R18 are defined herein. The invention also pertains to pharmaceutical compositions and compounds within the scope of formula (I) as well as medicaments and articles of manufacture comprising compounds of formula (I).
    Type: Application
    Filed: October 20, 2004
    Publication date: June 9, 2005
    Inventors: Eric Sartori, Magali Maillet, Marie Paugam, Eric Nicolai, Michael Lawrence, Karnail Atwal
  • 3,4-diaryloxazolone derivatives, their methods of preparation and their uses in therapeutics
    Patent number: 5866596
    Abstract: The present invention relates to the derivatives of formula: ##STR1## and to their use in therapeutics, especially as drugs with anti-inflammatory and analgesic properties.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: February 2, 1999
    Assignee: Laboratories UPSA
    Inventors: Eric Sartori, Jean-Marie Teulon
  • 3,4-diarylthiazolin-2-one or -2-thione derivatives, their methods of preparation and their uses in their methods of preparation and their uses in therapeutics
    Patent number: 5859036
    Abstract: The present invention relates to derivatives of formula ##STR1## and to their use in therapeutics especially as drugs with anti-inflammatory and analgesic properties.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: January 12, 1999
    Assignee: Laboratories UPSA
    Inventors: Eric Sartori, Jean-Marie Teulon
  • Analgesic .alpha.-amino-N-pyridylbenzenepropanamide derivatives and pharmaceutical compositions containing them
    Patent number: 5200408
    Abstract: The present invention relates to the derivatives of the formula ##STR1## in the (S) configuration, to their addition salts and to their use in therapy, especially as drugs with analgesic properties.
    Type: Grant
    Filed: March 11, 1992
    Date of Patent: April 6, 1993
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Eric Sartori, Jean-Marie Teulon